Piramal Pharma to hold 5th AGM, appoints new director

Piramal Pharma Limited (BSE: PPLPHARMA) will convene its 5th Annual General Meeting (AGM) on Wednesday, July 30, 2025, via video conferencing to discuss and approve key financial and strategic matters. The AGM will feature the adoption of audited financial statements for fiscal year 2024-25 and the declaration of a final dividend. Further, at the AGM, shareholders will consider the appointment of Mr. Amit Jain as a Non-Executive, Non-Independent Director, nominated by CA Alchemy Investments. The board has also recommended the reappointment of Mr. Jairaj Purandare as an Independent Director for a second term. The company is also seeking shareholder approval for the appointment of N L Bhatia & Associates as Secretarial Auditors for a five-year term, and ratification of remuneration for the Cost Auditors. Finally, the shareholders will consider the issuance of Non-Convertible Debentures on a private placement basis. The cut-off date is set on July 23, 2025. The remote e-voting will commence on July 26 and conclude on July 29, 2025.